Meinolf Karthaus, MD¹, M O Zahn^2*, B Tschechne^3*, B. Gerber^4*, S Haas^5*, U Schwindel^6*, M Konias^7*, A R Rotmann^8* and J Schilling^9*

¹Klinikum Neuperlach, Munich, Germany
²Onkologische Kooperation Harz, Goslar, Germany
³Hämato-Onkologische Praxis, Neustadt, Germany
⁴UFK Klinikum Südstadt, Rostock, Germany
⁵Friedrich-Ebert-Krankenhaus Neumuenster, Neumuenster, Germany
⁶I. Med. Klinik, Ruesselsheim, Germany
⁷Praxis Konias, Oranienburg, Germany
⁸Praxis Rotmann, Rodgau, Germany
⁹Praxisklinik, Berlin, Germany

Erica E. Fortune, PhD^1*, Melissa F. Miller, PhD, MPH^1*, Elissa C. Kranzler, PhD^1*, Jemeille Ackourey, MPH^2*, Kelly Clark, MA^1*, Heather Badt, MBA, LSS^3*, Linda Bohannon, RN, BSN, MSM^4*, Craig E. Cole, MD⁵, Thomas W. Leblanc^6,7,8 and Alexandra K Zaleta, PhD^1*

¹Research and Training Institute, Cancer Support Community, Philadelphia, PA
²Cancer Support Community, Philadelphia, PA
³Research & Training Institute, Cancer Support Community, Philadelphia, PA
⁴Cancer Support Community, Washington, DC
⁵Division of Hematology Oncology, Michigan State University, Lansing, MI
⁶Duke University School of Medicine, Durham, NC
⁷Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC
⁸Duke Cancer Institute, Durham, NC

Karl M Kilgore, PhD^1*, Anny C Wong, PhD^2*, Julia Thornton Snider, PhD^3*, Paul Cheng, MD, PhD³, Amy Schroeder, BPharm^4* and Iman Mohammadi, PhD^4*

¹Health Economics and Advanced Analytics, Avalere Health, An Inovalon Company, Towson, MD
²Health Economics and Advanced Analytics, Avalere Health, An Inovalon Company, Washington, DC
³Kite, A Gilead Company, Santa Monica, CA
⁴Avalere Health, An Inovalon Company, Washington, DC

Soon Khai Low, MD¹, Tarek Soliman Khattab^2*, Ali Hussein Dawood^3*, Rawan Al khudari^4*, Esraa Mahmoud Mostafa^5*, Amr Elhamamsy^6*, Amr Ebied, MD^7*, Shin Yin Lee, MD⁸ and Nguyen Tien Huy, MD, PhD^9*

¹Department of Internal Medicine, Rochester General Hospital, Rochester, NY
²Faculty of Medicine, Tanta University, Gharbia Governorate, Egypt
³Faculty of Medicine, Aswan University, Aswan Governorate, Egypt
⁴Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic
⁵Faculty of Medicine, Port Said University, Port Said, Egypt
⁶Faculty of Pharmacy, Tanta University, Tanta, Egypt
⁷Egyptian National Blood Transfusion Services, Giza, Egypt
⁸Billings Clinic, Billings, MT
⁹Department of Clinical Product Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan

Harsh Shah, DO¹, Seongho Kim, Ph.D^2*, Hyejeong Jang^3* and Ahmad S Halwani, MD⁴

¹University of Utah/ Huntsman Cancer Center, Salt Lake City, UT
²Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
³Department of Hematology/Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁴Huntsman Cancer Institute, Salt Lake City, UT

S Prockop, MD¹, R Dinavahi^2*, W Navarro, MD², N Guzman-Becerra^3*, Y Sun^3* and L Gamelin^2*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Atara Biotherapeutics, South San Francisco, CA
³Atara Biotherapeutics, Thousand Oaks, CA

John L Vaughn, MD¹, Laura C Pinheiro, PhD, MPH^2* and Narendranath Epperla, MD, MS³

¹Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
²Division of General Internal Medicine, Weill Cornell Medicine, New York, NY
³The Ohio State University James Comprehensive Cancer Center, Columbus, OH

Andrew Ip, MD, MSc¹, Anthony Mato, MD^2*, Jordan Intrator^3*, Nicholas P Howard^3*, Alessandra Petrillo, MD^3*, Rosalba Vicioso, BA^3*, Rani Sebti, MD^4*, Cristina Cicogna, MD^4*, Gabriella Magarelli, ACNP-BC^5*, Lori A. Leslie, MD^5*, Andre H. Goy, MD⁵ and Tatyana A. Feldman, MD³

¹Division of Lymphoma, Division of Outcomes and Value Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
³John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁴Center for Infectious Diseases, Hackensack University Medical Center, Hackensack, NJ
⁵Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

L Torno, MD^1*, A Dahlberg, MD^2*, Armin Ghobadi, MD³, P Stiff, MD⁴, R Reshef, MD⁵, W-K Weng, MD, PhD⁶, W Navarro, MD⁷, L Gamelin^7*, R Dinavahi^7*, Y Sun, PhD^8*, N Guzman-Becerra^8* and S Prockop, MD⁹

¹Hyundai Cancer Institute at CHOC Children's, Orange, CA
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Washington University School of Medicine, Saint Louis, MO
⁴Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood, IL
⁵Columbia University Irving Medical Center, New York, NY
⁶Division of Blood and Marrow Transplantation, Dept. of Medicine, Stanford Univ. School of Med., Stanford, CA
⁷Atara Biotherapeutics, South San Francisco, CA
⁸Atara Biotherapeutics, Thousand Oaks, CA
⁹Memorial Sloan Kettering Cancer Center, New York, NY

John L Vaughn, MD¹, Laura C Pinheiro, PhD, MPH^2*, Adam J Olszewski, MD³ and Narendranath Epperla, MD, MS⁴

¹Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY
²Division of General Internal Medicine, Weill Cornell Medicine, New York, NY
³Brown University, Providence, RI
⁴The Ohio State University James Comprehensive Cancer Center, Columbus, OH

Laura Fernandes, PhD^*, Jiaxi Zhou, MS^*, Bellinda L King-Kallimanis, PhD^*, Thomas Gwise, PhD^*, Paul Kluetz, MD^* and Vishal Bhatnagar, MD

U.S. Food and Drug Administration, Silver Spring, MD

Ghulam Rehman Mohyuddin^1*, Jill Hampton^1*, Muhammad Aziz^2*, Sadik Khuder, Ph.D^3*, Saad Ullah Malik, MD^4*, Brian McClune^5* and Al-Ola Abdallah, MD⁶

¹Kansas University Medical Center, Kansas City
²University of Toledo, Toledo
³Biostatistics, University of Toledo, Toledo, OH
⁴Marshall University, Huntington, WV
⁵University of Utah, Salt Lake City
⁶University of Kansas Medical Center, Westwood, KS

Owais Mian, BHSc^1*, Martine Puts, PhD, RN^2*, Arleigh McCurdy, MD, BSc³, Tanya M. Wildes, MD, MSc⁴, Mark A Fiala, MSW^5,6*, Matthew Kang, MD, FRCPC⁷, Mary Salib, MD⁸, Shabbir Alibhai, MD, MSc^9* and Hira S Mian, MD¹⁰

¹Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
²Lawrence S. Bloomberg, Faculty of Nursing, University of Toronto, Toronto, ON, Canada
³Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
⁴Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁵Washington University School of Medicine, Saint Louis, MO
⁶College for Public Health and Social Justice, Saint Louis University, Saint Louis, MO
⁷Department of Oncology, Joseph Brant Hospital: Cancer Clinic, Burlington, ON, CAN
⁸Department of Oncology, Walker Family Cancer Centre St. Catherine's General Hospital, St. Catherine, ON, CAN
⁹Department of Medicine, University of Toronto & University Health Network, Toronto, ON, Canada
¹⁰Department of Oncology, McMaster University, Hamilton, ON, Canada

Carlos Galvez, MD¹, Imran Nizamuddin, MD^2*, Emily Tuchman, MD^2*, Peter Doukas, MD^2*, Neha Reddy, MD^3*, Jessica K. Altman, MD⁴, Jane N. Winter, MD⁵, Leo I. Gordon, MD⁴, Dylan Barth, PharmD, BCPS^6*, Nicole Hodgins^7*, Barbara Pro, MD⁴, Shuo Ma, MD, PhD⁴, Shira Dinner, MD⁴, Olga Frankfurt, MD^4*, Jayesh Mehta, MD^4*, Seema Singhal, MD^4*, Kehinde Adekola, MBBS, MS⁴, Jonathan Moreira, MD^4*, Sajal D Tanna, MD, MPH^8*, Firas Wehbe, MD, PhD^9* and Reem Karmali, MD, MSc⁴

¹Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
²Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
³Department of Medicine, The University of Texas at Austin Dell Medical School, Austin, TX
⁴Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
⁵Division of Hematology and Oncology, Northwestern University, Chicago, IL
⁶Department of Pharmacy, Northwestern University Feinberg School of Medicine, Chicago, IL
⁷Georgetown University School of Medicine, Washington, DC
⁸Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL
⁹Northwestern University Feinberg School of Medicine, Chicago, IL

Cassandra P Wang, MD¹, Mashette Syrkin-Nikolau, MD, MA^2*, Lauge Farnaes, MD, PhD^3*, Doris Shen, PT^4*, Maria Kanegaye, RN^4* and Dennis John Kuo, MD, MS¹

¹Division of Pediatric Hematology and Oncology, UC San Diego, Rady Children's Hospital San Diego, San Diego, CA
²UC San Diego, Rady Children's Hospital San Diego, San Diego, CA
³Rady Children's Hospital, San Diego, CA
⁴Division of Pediatric Hematology and Oncology, Rady Children's Hospital San Diego, San Diego, CA

Andrew J. Belli, MPH^1*, Eric Hansen, MS^1*, Ankit Kansagra, MD², Keshava Dilwali, MS^1* and Ching-Kun Wang, MD^1*

¹COTA, Inc., Boston, MA
²Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX

Michael M. Song, MD, PhD, PharmD¹, Abhishek Pandya, DO², K Tai Lucero, MD^1*, James J Yoo, MD¹, Joel E Michalek, PhD^3*, Qianqian Liu, PhD^4* and Adolfo Enrique Diaz Duque, MD, MSc⁵

¹Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, TX
²University of Texas Health Science Center San Antonio, San Antonio, TX
³The University of Texas Health Science Center At San Antonio, San Antonio, TX
⁴Department of Epidemiology and Biostatistics, University of Texas Health at San Antonio, San Antonio, TX
⁵Hematology-Oncology Division, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX

Amin Firoozmand, MD^1*, Naveed Ali, MD², Nausheen Ahmed, MD^3*, Pingfu Fu^4*, Shufen Cao^5*, George Brown^6*, Hannah Schmikla, RN^1*, James J. Driscoll, MD, PhD⁷, Timothy O'Brien^6*, Paolo Caimi, MD^8,9, Marcos de Lima, MD^8,10 and Ehsan Malek, MD^11,12

¹University Hospitals Cleveland Medical Center, Cleveland, OH
²Case Western Reserve University, University Heights, OH
³KANSAS UNIVERSITY, KANSAS, KS
⁴university hospitals cleveland medical center, cleveland
⁵Case Western Reserve University, Cleveland, OH
⁶University Hospitals Cleveland Medical Center, cleveland
⁷Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
⁸Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
⁹University Hospitals Seidman Cancer Center, Cleveland, OH
¹⁰Adult Hematologic Malignancies & St, Cleveland, OH
¹¹University Hospitals Case Medical Center, Cleveland, OH
¹²Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Hts, OH

Omar Nadeem, MD^1*, Paul G. Richardson, MD¹, María-Victoria Mateos, MD, PhD², Albert Oriol^3*, Alessandra Larocca⁴, Joan Blade Creixenti⁵, Paula Rodríguez-Otero, MD^6*, Xavier Leleu, MD⁷, Maxim Norkin, MD, PhD^8*, John W. Hiemenz, MD^9*, Hani Hassoun, MD¹⁰, Cyrille Touzeau^11,12,13*, Adrián Alegre Amor, MD, PhD^14*, Agne Paner, MD¹⁵, Christopher Maisel, MD¹⁶, Amitabha Mazumder, MD^17*, Anastasios Raptis, MD¹⁸, Noemí Puig, MD, PhD^2*, Anna Sandberg, MmSc^19*, Ivonne Pelaez, MD^19*, Christian Jaques, MD^19*, Marie Orre, PhD^19* and Michele Cavo^20*

¹Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
³Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁴Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
⁵Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁶Clínica Universidad de Navarra, Pamplona, Spain
⁷CHU de Poitiers, Poitiers, France
⁸Baptist MD Anderson Cancer Center, Jacksonville, FL
⁹Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
¹⁰Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France
¹²Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
¹³Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France
¹⁴Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain
¹⁵Rush University Medical Center, Chicago, IL
¹⁶Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX
¹⁷The Oncology Institute of Hope and Innovation, Glendale, CA
¹⁸Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
¹⁹Oncopeptides AB, Stockholm, Sweden
²⁰Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Tanya Siddiqi, MD¹, Ulrich Jaeger, MD², Olga Moshkovich, MPH^3*, Jennifer Devlen, PhD^3*, Matthew Miera, BSc^3*, Agnes Williams, MSc^4*, Jens Hasskarl, MD^5*, Fei Fei Liu, BSc, MBA^6*, Julia Braverman, PhD^6* and Gilles Salles, MD, PhD⁷

¹Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
²Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AA, Austria
³ICON PLC, Gaithersburg, MD
⁴ICON PLC, London, United Kingdom
⁵Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
⁶Bristol Myers Squibb, Princeton, NJ
⁷Centre Hospitalier Lyon-Sud, Lyon, France

Christopher Kim, PhD¹, Megan Braunlin, MPH^2*, Rajesh Belani, MD^3* and John Travis Wheeling, MPH^4*

¹Amgen, Inc., Los Angeles, CA
²Amgen, Inc., Austin, TX
³Amgen, Inc., Thousand Oaks, CA
⁴DOCS Global, Philadelphia, PA